Abstract
Wearables, apps and other remote smart devices can capture rich, objective physiologic, metabolic, and behavioral information that is particularly relevant to pregnancy. The objectives of this paper were to 1) characterize individual level pregnancy self-reported symptoms and objective features from wearables compared to the aggregate; 2) determine whether pregnancy self-reported symptoms and objective features can differentiate pregnancy-related conditions; and 3) describe associations between self-reported symptoms and objective features. Data are from the Better Understanding the Metamorphosis of Pregnancy study, which followed individuals from preconception to three-months postpartum. Participants (18-40 years) were provided with an Oura smart ring, a Garmin smartwatch, and a Bodyport Cardiac Scale. They also used a study smartphone app with surveys and tasks to measure symptoms. Analyses included descriptive spaghetti plots for both individual-level data and cohort averages for select weekly reported symptoms and objective measures from wearables. This data was further stratified by pregnancy-related clinical conditions such as preeclampsia and preterm birth. Mean Spearman correlations between pairs of self-reported symptoms and objective features were estimated. Self-reported symptoms and objective features during pregnancy were highly heterogeneous between individuals. While some aggregate trends were notable, including an inflection in heart rate variability approximately eight weeks prior to delivery, these average trends were highly variable at the n-of-1 level, even among healthy individuals. Pregnancy conditions were not well differentiated by objective features. With the exception of self-reported swelling and body fluid volume, self-reported symptoms and objective features were weakly correlated (mean Spearman correlations <0.1).
High heterogeneity and complexities of associations between subjective experiences and objective features across individuals pose challenges for researchers and highlights the dangers in reliance on aggregate approaches in the use of wearable data in pregnant individuals. Innovation in machine learning and AI approaches at the n-of-1 level could help to accelerate the field.
Author Summary The objective physiological and behavioral information from wearable and other smart devices is uniquely relevant to pregnancy. The objectives of this study were to: 1) describe the individual-level variability of pregnancy self-reported symptoms and objective wearable measures; 2) determine whether this variability can be explained by pregnancy clinical conditions; and 3) determine whether pregnancy self-reported symptoms are associated with objective wearable measures. Data are from the Better Understanding the Metamorphosis of Pregnancy study, which followed individuals from preconception to three-months postpartum. Participants (18-40 years) used an Oura smartring, a Garmin smartwatch, and a Bodyport Cardiac Scale alongside a study app to track self-reported symptoms. High heterogeneity was observed in self-reported pregnancy symptoms, and objective measures such as heart rate variability, activity and sleep over pregnancy that were dissimilar to the population average of these measures. Pregnancy clinical conditions did not explain well the observed high variability in objective wearable measures while self-reported symptoms were weakly correlated with objective wearable measures over pregnancy. In sum, high heterogeneity and complexities of associations between subjective experiences and objective measures from wearables across pregnant individuals pose challenges for researchers. Innovation in machine learning and AI individual level approaches will help to accelerate the field.
Competing Interest Statement
CC and SS are employees of Bodyport Inc.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The BUMP study was ethically approved by the Institutional Review Board, Advarra (Pro00047893).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Among participants who opt-in, coded study data from the BUMP study participants is available on the Synapse platform (synapse.org) at Sage Bionetworks (https://sagebionetworks.org) and can be freely accessed by any researcher who becomes ‘qualified’ by becoming a registered and certified Synapse user (https://help.synapse.org/docs/User-Account-Tiers.2007072795.html), and by meeting the specific conditions of use that require submitting an intended data use statement alongside an IRB approved protocol. The BUMP specific Synapse Project page can be found here: https://www.synapse.org/#!Synapse:syn25953345/wiki/616547 among registered Synapse users.
